Regulation
The FDA vs. Commercial Speech
How restricting the promotion of "off-label" pharmaceutical use puts doctors and patients at risk
The EPA vs. the Constitution
The Supreme Court prepares to hear a major Fifth Amendment case.
How restricting the promotion of "off-label" pharmaceutical use puts doctors and patients at risk
The Supreme Court prepares to hear a major Fifth Amendment case.